| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5892322 | Bone | 2008 | 5 Pages |
Abstract
Men with prostate cancer, particularly those treated with ADT, had an increased fracture risk. Although the average BMD in men with prostate cancer was higher than men without cancer, a low BMD prior to treatment or increased rate of bone loss after initiating ADT treatment was each a significant predictor of fracture in these.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Henrik G. Ahlborg, Nguyen D. Nguyen, Jacqueline R. Center, John A. Eisman, Tuan V. Nguyen,